brightspring health services inc - BTSG

BTSG

Close Chg Chg %
43.31 1.51 3.49%

Closed Market

44.82

+1.51 (3.49%)

Volume: 3.98M

Last Updated:

Mar 25, 2026, 4:00 PM EDT

Company Overview: brightspring health services inc - BTSG

BTSG Key Data

Open

$43.81

Day Range

43.74 - 45.59

52 Week Range

15.48 - 45.59

Market Cap

$8.38B

Shares Outstanding

193.55M

Public Float

122.85M

Beta

2.33

Rev. Per Employee

N/A

P/E Ratio

49.92

EPS

$0.94

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

4.12M

 

BTSG Performance

1 Week
 
8.76%
 
1 Month
 
8.18%
 
3 Months
 
18.73%
 
1 Year
 
148.59%
 
5 Years
 
N/A
 

BTSG Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 16
Full Ratings ➔

About brightspring health services inc - BTSG

BrightSpring Health Services, Inc. engages in the provision of a platform of complementary health services delivering and pharmacy solutions for complex populations in home and community settings. It operates under the Pharmacy Solutions and Provider Services segments. The Pharmacy Solutions segment includes infusion and specialty pharmacy, and home and community pharmacy. The Provider Services segment is involved in home health care and community and rehab care. The company was founded in 1974 and is headquartered in Louisville, KY.

BTSG At a Glance

BrightSpring Health Services, Inc.
805 North Whittington Parkway
Louisville, Kentucky 40222
Phone 1-502-394-2100 Revenue 12.91B
Industry Medical/Nursing Services Net Income 190.67M
Sector Health Services 2025 Sales Growth 14.593%
Fiscal Year-end 12 / 2026 Employees 500
View SEC Filings

BTSG Valuation

P/E Current 49.919
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 43.165
Price to Sales Ratio 0.638
Price to Book Ratio 3.837
Price to Cash Flow Ratio 16.79
Enterprise Value to EBITDA 18.976
Enterprise Value to Sales 0.841
Total Debt to Enterprise Value 0.249

BTSG Efficiency

Revenue/Employee 25,821,128.00
Income Per Employee 381,332.00
Receivables Turnover 12.041
Total Asset Turnover 2.047

BTSG Liquidity

Current Ratio 1.565
Quick Ratio 1.124
Cash Ratio 0.048

BTSG Profitability

Gross Margin 11.756
Operating Margin 3.161
Pretax Margin 1.068
Net Margin 1.477
Return on Assets 1.687
Return on Equity 6.038
Return on Total Capital 2.321
Return on Invested Capital 2.389

BTSG Capital Structure

Total Debt to Total Equity 144.381
Total Debt to Total Capital 59.08
Total Debt to Total Assets 42.213
Long-Term Debt to Equity 138.937
Long-Term Debt to Total Capital 56.853
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Brightspring Health Services Inc - BTSG

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
7.72B 8.83B 11.27B 12.91B
Sales Growth
+15.27% +14.32% +27.65% +14.59%
Cost of Goods Sold (COGS) incl D&A
6.37B 7.39B 9.68B 11.39B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
203.97M 202.34M 204.48M 164.28M
Depreciation
77.50M 79.20M 89.70M 71.80M
Amortization of Intangibles
126.47M 123.14M 114.78M 92.48M
COGS Growth
+16.82% +16.12% +30.92% +17.72%
Gross Income
1.35B 1.43B 1.59B 1.52B
Gross Income Growth
+8.49% +5.87% +10.79% -4.45%
Gross Profit Margin
+17.54% +16.24% +14.10% +11.76%
2022 2023 2024 2025 5-year trend
SG&A Expense
1.06B 1.24B 1.28B 1.11B
Research & Development
- - - -
-
Other SG&A
1.06B 1.24B 1.28B 1.11B
SGA Growth
+7.99% +17.56% +3.19% -13.55%
Other Operating Expense
- - - -
-
Unusual Expense
108.20M 42.58M 111.11M 112.81M
EBIT after Unusual Expense
187.83M 147.18M 193.65M 295.25M
Non Operating Income/Expense
- - - -
-
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
233.58M 324.59M 228.39M 157.31M
Interest Expense Growth
+41.29% +38.96% -29.64% -31.12%
Gross Interest Expense
233.58M 324.59M 228.39M 157.31M
Interest Capitalized
- - - -
-
Pretax Income
(45.75M) (177.41M) (34.74M) 137.94M
Pretax Income Growth
-166.44% -287.75% +80.42% +497.09%
Pretax Margin
-0.59% -2.01% -0.31% +1.07%
Income Tax
8.46M (20.58M) (14.22M) 33.15M
Income Tax - Current - Domestic
36.38M 32.01M 16.94M 27.56M
Income Tax - Current - Foreign
43.00K 40.00K 50.00K 35.00K
Income Tax - Deferred - Domestic
(27.96M) (52.63M) (31.21M) 5.55M
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(54.22M) (156.84M) (20.52M) 104.80M
Minority Interest Expense
(312.00K) (2.23M) (2.46M) (1.55M)
Net Income
(53.91M) (154.60M) (18.06M) 106.35M
Net Income Growth
-208.25% -186.80% +88.32% +688.80%
Net Margin Growth
-0.70% -1.75% -0.16% +0.82%
Extraordinaries & Discontinued Operations
- - - 84.32M
-
Discontinued Operations
- - - 84.32M
-
Net Income After Extraordinaries
(53.91M) (154.60M) (18.06M) 190.67M
Preferred Dividends
- - - -
-
Net Income Available to Common
(53.91M) (154.60M) (18.06M) 190.67M
EPS (Basic)
-0.3149 -0.9031 -0.1037 0.9413
EPS (Basic) Growth
-208.25% -186.79% +88.52% +1,007.71%
Basic Shares Outstanding
171.19M 171.19M 174.25M 202.56M
EPS (Diluted)
-0.3149 -0.9031 -0.1037 0.8676
EPS (Diluted) Growth
-208.25% -186.79% +88.52% +936.64%
Diluted Shares Outstanding
171.19M 171.19M 174.25M 219.77M
EBITDA
500.00M 392.10M 509.24M 572.34M
EBITDA Growth
+6.97% -21.58% +29.88% +12.39%
EBITDA Margin
+6.48% +4.44% +4.52% +4.43%

Snapshot

Average Recommendation BUY Average Target Price 52.267
Number of Ratings 16 Current Quarters Estimate 0.303
FY Report Date 03 / 2026 Current Year's Estimate 1.553
Last Quarter’s Earnings 0.33 Median PE on CY Estimate N/A
Year Ago Earnings 1.00 Next Fiscal Year Estimate 1.954
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 14 14 15 16
Mean Estimate 0.30 0.36 1.55 1.95
High Estimates 0.39 0.44 1.76 2.48
Low Estimate 0.21 0.25 1.21 1.35
Coefficient of Variance 15.23 13.81 9.85 13.23

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 16 15 16
OVERWEIGHT 0 0 0
HOLD 0 0 1
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Buy

Insider Actions for Brightspring Health Services Inc - BTSG

Date Name Shares Transaction Value
Jul 31, 2025 Jon B. Rousseau See Remarks; Director 1,131,930 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $20.53 per share 23,238,522.90
Jul 30, 2025 Scott Greenwell President, PharMerica 16,839 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 30, 2025 Scott Greenwell President, PharMerica 35,920 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Brightspring Health Services Inc in the News